Sodium Assay Reagent Kit (Galactosidase Method) - NMPA Registration 冀械注准20142400346
Access comprehensive regulatory information for Sodium Assay Reagent Kit (Galactosidase Method) in the China medical device market through Pure Global AI's free database. This Class II medical device is registered under NMPA registration number 冀械注准20142400346 and owned by Langfang Hengyi Biotechnology Co., Ltd.. The device was approved on November 07, 2019.
This page provides complete registration details including registrant information, province location (Hebei), intended use, and regulatory compliance data from the official China NMPA medical device database. Pure Global AI offers free access to China's complete medical device registry, helping global MedTech companies navigate NMPA regulations efficiently.
It is used for the quantitative determination of sodium content in human serum in vitro.
用于体外定量测定人体血清中钠的含量。
Reagent 1: magnesium ion, 9mmol/L; O-Nitrophenol-β-galactopyranose, 19.7 mmol/L. Reagent 2: β-galactosidase, 88.5 mmol/L
试剂1：镁离子，9mmol/L；O-硝基酚-β-吡喃半乳糖，19.7mmol/L。试剂2：β-半乳糖苷酶，88.5mmol/L